Flagship Pioneering’s David Berry founded Valo Health 18 months ago with an eye to making an AI platform to develop drugs more quickly and efficiently.
Category: alexknappblog
Lilly’s Rheumatoid Arthritis Drug Shortens Covid-19 Hospitalization When Combined With Antiviral Med
The pharmaceutical company said its drug baricitinib, combined with remdesivir, reduces median hospital stays by one day compared to remdesivir alone, and is pursuing an emergency use authorization with the FDA.
2021 Breakthrough Prize Winners Announced: Researcher Who Developed Protein Design Technology Awarded $3 Million
David Baker, whose protein design technology is being used to develop therapies for Covid-19 and cancer, received one of several awards to scientists from the Breakthrough Prize Foundation that add up to a combined total of $21.75 million.
The Inside Story Of Biotech’s Barnum And His Covid Cures
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”
Mammoth Biosciences Signs Exclusive Deal For Recently-Discovered Crispr Protein
Biotech company Mammoth Biosciences has signed an exclusive deal with University of California Berkeley to license a newly-discovered class of Crispr proteins.
This Startup Aims To Bring Hospital-Grade Disinfection To Hotels, Restaurants And Schools
This group of Silicon Valley veterans have joined forces with an environmental scientist to bring hospital grade UV-C disinfection to schools and to businesses like hotels and restaurants.
Lilly Has Begun Phase 3 Clinical Trials To See If Its Rheumatoid Arthritis Drug Treats Covid-19
The Indianapolis-based pharmaceutical giant hopes to enroll up to 400 people in a study to see if its drug baricitinib can treat patients with severe cases of Covid-19.
The Insider’s Guide To Reopening America
Expert advice for behaving responsibly during the next phase of the pandemic.
AbCellera Raises $105 Million To Boost Drug Discovery Against Coronavirus And Other Diseases
The Vancouver-based biotech firm aims to nearly double its headcount and expand its R&D efforts to find antibodies to treat disease.
Novavax Is Beginning Clinical Trials Of Its Coronavirus Vaccine
Novavax announced it’s beginning clinical trials of its Covid-19 vaccine on Monday.
